Inflammatory Mediators and Neuromodulators: Targeting in Asthma and Chronic Obstructive Pulmonary Disease
Book:
Frontiers in Clinical Drug Research – Anti Allergy Agents
Page:
3-44
Author(s):
Soledad Gori, Julieta María Alcain, Gabriela Salamone and Mónica Vermeulen
Neural Networks in Schizoaffective Disorder
Book:
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder
Page:
45-51
Author(s):
Felix-Martin Werner and Rafael Coveñas
Schizoaffective Disorder: Alterations of Neurotransmitters and Neuropeptides in Brain Centers Involved in Psychotic and Affective Symptoms
Book:
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder
Page:
13-36
Author(s):
Felix-Martin Werner and Rafael Coveñas
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder: Focus on Prophylactic Medication
Book:
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder
Page:
3-6
Author(s):
Felix-Martin Werner and Rafael Coveñas
Biopolymers for Neurotherapeutic Interventions
Book:
Frontiers in Biomaterials
Page:
353-380
Author(s):
Valence M.K. Ndesendo
Cardiovascular Actions of Estrogens
Book:
Women’s Heart and Estrogens
Page:
31-94
Author(s):
Genovefa D. Kolovou
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinson’s Disease
Book:
Recent Advances in Medicinal Chemistry
Page:
59-75
Author(s):
Erika B. Villanueva, Jonathan P. Little and Andis Klegeris
Nutritional Approaches in Alzheimer's Disease Prevention
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
236-260
Author(s):
Lili Chen, Shishu Huang, Zhi-Gang Zhang, Cheung Toa Ng, Yat-Fung Shea, Leung-Wing Chu, Liqiu Wang, Yan Li and You-Qiang Song
Some Questions Posed About the Prevention and Treatment of Alzheimer’s Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
128-175
Author(s):
Margaret M. Esiri and Gordon K. Wilcock
Pharmaceutical and Nutritional Benefits in Alzheimer's Disease via Convergence on the Melatoninergic Pathways
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
50-127
Author(s):
George Anderson and Michael Maes